Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
biOasis Technologies Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'biOasis Technologies Inc. - Product Pipeline Review - 2014', provides an overview of the biOasis Technologies Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of biOasis Technologies Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of biOasis Technologies Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of biOasis Technologies Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the biOasis Technologies Inc.'s pipeline products Reasons to buy - Evaluate biOasis Technologies Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of biOasis Technologies Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the biOasis Technologies Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of biOasis Technologies Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of biOasis Technologies Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of biOasis Technologies Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 biOasis Technologies Inc. Snapshot 4 biOasis Technologies Inc. Overview 4 Key Information 4 Key Facts 4 biOasis Technologies Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 biOasis Technologies Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 biOasis Technologies Inc. - Pipeline Products Glance 9 biOasis Technologies Inc. - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 biOasis Technologies Inc. - Drug Profiles 10 BT-2111 10 Product Description 10 Mechanism of Action 10 R&D Progress 10 BT-2211 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 MTf-I2S 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 MTfp-I2S 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Recombinant Enzyme for Hurler Syndrome 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RNAi Oligonucleotide to Inhibit Nox4 for Central Nervous System Disorders 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 transcend doxorubicin conjugate 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 biOasis Technologies Inc. - Pipeline Analysis 19 biOasis Technologies Inc. - Pipeline Products by Target 19 biOasis Technologies Inc. - Pipeline Products by Route of Administration 20 biOasis Technologies Inc. - Pipeline Products by Molecule Type 21 biOasis Technologies Inc. - Pipeline Products by Mechanism of Action 22 biOasis Technologies Inc. - Recent Pipeline Updates 23 biOasis Technologies Inc. - Locations And Subsidiaries 24 Head Office 24 Other Locations & Subsidiaries 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables biOasis Technologies Inc., Key Information 4 biOasis Technologies Inc., Key Facts 4 biOasis Technologies Inc. - Pipeline by Indication, 2014 6 biOasis Technologies Inc. - Pipeline by Stage of Development, 2014 7 biOasis Technologies Inc. - Monotherapy Products in Pipeline, 2014 8 biOasis Technologies Inc. - Preclinical, 2014 9 biOasis Technologies Inc. - Pipeline by Target, 2014 19 biOasis Technologies Inc. - Pipeline by Route of Administration, 2014 20 biOasis Technologies Inc. - Pipeline by Molecule Type, 2014 21 biOasis Technologies Inc. - Pipeline Products by Mechanism of Action, 2014 22 biOasis Technologies Inc. - Recent Pipeline Updates, 2014 23 biOasis Technologies Inc., Subsidiaries 24
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.